Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Change in Account Payables (2021 - 2025)

Invivyd's (IVVD) quarterly Change in Account Payables came in at -$4.2 million in Q4 2025, up 41.76% on a YoY basis from -$3.0 million in Q4 2024, and down 1847.71% quarter-over-quarter from -$218000.0 in Q3 2025.

Analysis

Invivyd (IVVD) Change in Account Payables (2021 - 2025) Analysis & Trends

Invivyd (IVVD) has reported Change in Account Payables for 5 consecutive years, with -$4.2 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables rose 41.76% year-over-year to -$4.2 million; the trailing twelve-month figure through Dec 2025 stood at $3.2 million (up 32.52% YoY), and the FY2025 full-year result was $3.2 million, up 32.52% from the prior year.
  • Change in Account Payables eased to -$4.2 million in Q4 2025 per IVVD's latest filing, from -$218000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $12.9 million in Q1 2022 and bottomed at -$14.7 million in Q4 2022.
  • Historically, Change in Account Payables has averaged $271750.0 across 5 years, with a median of -$611500.0 in 2021.
  • The widest YoY moves for Change in Account Payables: up 443.75% in 2024, down 500.58% in 2024.
  • Over 5 years, Change in Account Payables stood at -$11.3 million in 2021, then sank by 30.07% to -$14.7 million in 2022, then soared by 91.73% to -$1.2 million in 2023, then tumbled by 500.58% to -$7.3 million in 2024, then jumped by 41.76% to -$4.2 million in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods registered -$4.2 million, -$218000.0, and $9.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -70.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 18.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -66.70 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -8.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -4.25 Mn
Sep 30, 2025 -218,000.00
Jun 30, 2025 9.31 Mn
Mar 31, 2025 -1.64 Mn
Dec 31, 2024 -7.29 Mn
Sep 30, 2024 10.31 Mn
Jun 30, 2024 6.19 Mn
Mar 31, 2024 -6.79 Mn
Dec 31, 2023 -1.21 Mn
Sep 30, 2023 5.06 Mn
Jun 30, 2023 -1.80 Mn
Mar 31, 2023 4.43 Mn
Dec 31, 2022 -14.67 Mn
Sep 30, 2022 1.92 Mn
Jun 30, 2022 -4.45 Mn
Mar 31, 2022 12.90 Mn
Dec 31, 2021 -11.28 Mn
Sep 30, 2021 6.75 Mn
Jun 30, 2021 -1.01 Mn
Mar 31, 2021 3.16 Mn